Flow Cytometry Market Report, published by Allied Market Research, forecasts that the global market was valued $2,257.2 million in 2014, and is expected to reach$7,027 million by 2022, growing at a CAGR of 16.0% during the period 2015 - 2022.Increasing needs to enhance precisions and produce faster results as well as a need for compact devices are compelling the clinical and diagnostic organization to adopt innovative technologies. Though popularity has been gained in the application field of life science industry, the cost of the instrument is impeding the growth. Due to this, many researchers are still reluctant in adopting this technology in their research work. Moreover, advancing technologies that has brought complex instrumentation requires highly skilled personals to operate these instruments.

The Flow cytometry market is in developing phase. Enhancing precision in the results and the presence of numerous flow cytometry techniques such as multicolor and multi-parameter flow cytometry has acted as a strong foothold, assisting the market growth in the majority of the developed economies and foresees high potential in the emerging economies such as Asia Pacific and Africa. These economies have high demand for better health care techniques at an affordable cost. Increasing agepopulation who needs better healthcare, increase in chronic disease and need for better diagnosis and treatment are few driving factors that are impacting the flow cytometry market state AMR analysts Debbie Shields and Rohini Patil.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

The report provides a comprehensive analysis of the leading companies operating in the flow cytometry industry. Key companies profiled in the report are Danaher Corporation (Beckman Coulter), Becton, Dickinson and Company, EMD Millipore, Sysmex Corporation, Affymetix Inc., Luminex Corporation, Thermo Fischer Scientific, Bio-Rad Laboratories, Inc., Miltenyi Biotec, Inc. and Agilent Technologies, Inc.


𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/90

The global market for flow cytometry is divided into segments such as products, technology, end users, and applications. Instruments market accounts for the largest share of revenue in the flow cytometry market at present and is expected to remain as the highest revenue generator in 2020. Increase in modularity, accessibility, incorporation of imaging capabilities, availability of wavelengths and targets and size reduction are a few of the significant trends in the market assisting in the adoption of the instruments by the end users. On the other hand, reagents market is expected to experience the highest growth rate of CAGR 12% during the analysis period. A Primary reason escalating this segment is availability of several types of reagents that find diverse usability depending on specific applications like diagnostics, drug discovery, etc.


𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/90


North America accounted for the largest share of revenue i.e. 43.5% of the overall Global flow cytometry market at $1.2 billion in 2011. The region is further expected to attain a market size of $2.8 billion by 2020 growing at a CAGR of 10.1%. The company profile in this includes: Advanced analytical Technologies, Inc., Merck Millipore, Becton, Dickinson & co, Beckman Coulter, eBioscience, Partech, Life technologies corp., Luminex Corp, Amnis Corp., Morphosys AG. The primary strategy employed by key players of the market is products launch, which is due to demand for newer, faster, and higher through put machines that deliver better results.

𝗚𝗲𝘁 𝗗𝗲𝘁𝗮𝗶𝗹𝗲𝗱 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/flow-cytometry-market